TITLE:
The Safety of Four Different Dose Levels of Wobenzym in HIV-Positive Patients

CONDITION:
HIV Infections

INTERVENTION:
Wobenzym

SUMMARY:

      To study the safety and efficacy of four different doses of Wobenzym (an enzyme combination
      consisting of pancreatin, papain, bromelain, trypsin, lipase, amylase, chymotrypsin, and
      rutin) in patients with HIV infection whose CD4 count is between 250 and 400 cells/mm3. To
      evaluate the effect of Wobenzym on certain surrogate markers associated with progression of
      HIV disease.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 18 Years to N/A
Criteria:

        Inclusion Criteria

        Patients must have:

        HIV seropositivity with CD4 counts between 250 and 400 cells/mm3.

        Exclusion Criteria

        Co-existing Condition:

        Patients with the following symptoms or conditions are excluded:

          -  Known hypersensitivity to hydrolytic enzymes such as Wobenzym.

          -  Known sensitivity to lactose.

          -  Presumption that the patient will not comply with the dosing schedule or follow-up
             appointments.

        Concurrent Medication:

        Excluded:

          -  Concurrent use of immunosuppressive therapy or steroids.
      
